Skip to main content
Clinical Trials/NL-OMON46916
NL-OMON46916
Completed
Not Applicable

Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation - DIRECT-DBS

Boston Scientific Cooperation International0 sites4 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Boston Scientific Cooperation International
Enrollment
4
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
December 19, 2018
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Boston Scientific Cooperation International

Eligibility Criteria

Inclusion Criteria

  • IC1\. Candidate for Vercise\* PC DBS with bilateral implant of BSN DBS Directional Leads in STN, and meets:
  • Diagnosis of bilateral idiopathic PD with the presence of rigidity and at least one (1\) of the following: resting tremor or bradykinesia.
  • UPDRS III score of \>25 in the meds OFF condition
  • Medication must improve PD symptoms by \>\=30%, as measured by UPDRS subset III score
  • IC2\. Willing and able to comply with all visits, including required travel, and with study related procedures
  • IC3\. Meets all requirements of Vercise\* PC Local Directions For Use (DFU)
  • IC4\. Able to understand the study requirements and the treatment procedures and provides written informed consent before any study\-specific tests or procedures are performed

Exclusion Criteria

  • EC1\. Any significant psychiatric problems, including unrelated clinically significant depression as determined by the investigator
  • EC2\. Any current drug or alcohol abuse as determined by the investigator
  • EC3\. Any history of recurrent or unprovoked seizures
  • EC4\. Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival \<12 months

Outcomes

Primary Outcomes

Not specified

Similar Trials